A Message from Program Leaders


Dear Prospective Applicants:

We invite you to explore our Hematology/Oncology Fellowship Training Program at Beth Israel Deaconess Medical Center (BIDMC), a major teaching affiliate of Harvard Medical School. For over 40 years, ours has been a traditional combined training program in Hematology and Medical Oncology. With the growth in both disciplines, the Division of Hematology/Oncology became two divisions in 2019: the Division of Hematology & Hematologic Malignancies and the Division of Medical Oncology.

In 2021, the American Society of Hematology (ASH) announced a request for proposals for ASH-sponsored Hematology-Focused Fellowship Training Programs. BIDMC was one of nine institutions nationwide to receive an HFFTP award, which will fund recruitment of one fellow each year to a three-year Hematology Track. Recruitment for this track, alongside recruitment of six fellows to the Traditional Hematology/Oncology Track, will commence in 2022, with a start date of July 1, 2023.

Our aim is to produce scholars who will devote their careers, in different proportions, to excellence in clinical care, teaching, and clinical/basic research. Every effort is made to tailor the experience to the individual interests and needs of our trainees. We expect that all graduates of our program will become first-class clinicians, teachers, and investigators. In recognition of the program's success in producing physician-scientists, the NIH has provided training grant support to the program for over 30 years.

We have diverse and active clinical investigative initiatives in:

  • hematopoietic cell transplantation
  • biologic and immunotherapies
  • cellular therapies
  • genitourinary malignancies
  • breast cancer
  • lung cancer
  • head and neck cancer
  • gastrointestinal malignancies
  • AIDS-related malignancies
  • developmental therapeutics
  • hemostasis and thrombosis

Basic research programs include:

  • signal transduction and growth regulation
  • the role of transcription factors in hematopoiesis
  • molecular analysis of hematopoietic stem cell differentiation
  • biology of prostate cancer and the molecular basis of hormone-independent prostate cancer growth
  • biology of AIDS-related malignancies
  • T-cell receptor biology as applied to gene therapy
  • hemostasis, thrombosis, and vascular biology
  • cancer-related thrombosis
  • platelet biology
  • molecular retrovirology and HIV-gene therapy
  • the immunobiology of cytokines
  • cellular therapies

We welcome you to explore our website in detail and learn more about us. Please feel free to contact us with any questions you may have or to discuss your areas of interest.

Sincerely,

Dr. Deepa Rangachari, Director of Graduate Medical Education & Fellowship Program Director
Dr. Rushad Patell, Associate Fellowship Program Director
Dr. Reed Drews, Emeritus Fellowship Program Director, Associate Fellowship Program Director (HFFTP)
Roshanda Leak, Fellowship Program Coordinator

Hematology/Oncology Leadership and Faculty

Learn more about BIDMC's Hematology/Oncology Fellowship Program faculty below.

Dr. Deepa Rangachari

Dr. Deepa Rangachari

Director of Graduate Medical Education & Fellowship Program Director

Dr. Rushad Patell

Dr. Rushad Patell

Associate Fellowship Program Director

Reed Drews, MD

Dr. Reed Drews

Emeritus Fellowship Program Director, Associate Fellowship Program Director (HFFTP)

Roshanda Leak

Roshanda Leak

Fellowship Program Coordinator

Daniel B. Costa, MD, PhD

Dr. Daniel Costa

Scholarship Advisor for Medical Oncology

Dr. Jacalyn Rosenblatt

Dr. Jacalyn Rosenblatt

Scholarship Advisor for Hematologic Malignancies

Dr. Jeffrey Zwicker

Dr. Jeffrey Zwicker

Scholarship Advisor for Hematology